Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL -0.55%72 OCF Yield % is 8.38 as of Jul. 14, 2026, which is 51% above its 10-year median of 5.54. GuruFocus rates ISX:HEAL with a GF Score™ of 72/100 and a GF Value™ of Rp1,582.89 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 63.69% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's OCF Yield % or its related term are showing as below:
ISX:HEAL'
s OCF Yield % Range Over the Past 10 Years
Min: 0.48 Med: 5.54 Max: 13.17
Current: 8.38
During the past 11 years, the highest OCF Yield % of PT Medikaloka Hermina Tbk was 13.17%. The lowest was 0.48%. And the median was 5.54%.
ISX:HEAL's OCF Yield % is ranked better than 63.69% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.47
vs ISX:HEAL: 8.38
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PT Medikaloka Hermina Tbk OCF Yield % Related Terms
PT Medikaloka Hermina Tbk OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's OCF Yield % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a OCF Yield % of 8.38 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 51% above median its historical median of 5.54. Over the past decade, PT Medikaloka Hermina Tbk's OCF Yield % has ranged from 0.48 to 13.17. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #248 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 36.3%.
Is PT Medikaloka Hermina Tbk's OCF Yield % too high?
PT Medikaloka Hermina Tbk's current OCF Yield % of 8.38 is 51% above median its 10-year median of 5.54. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 13.17. The Healthcare Providers & Services industry median OCF Yield % is 5.47. PT Medikaloka Hermina Tbk's value of 8.38 is 53.2% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #248 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #248 out of 683 companies for OCF Yield %. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median OCF Yield % is 5.47. PT Medikaloka Hermina Tbk's value of 8.38 is 53.2% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own OCF Yield % has ranged from 0.48 to 13.17 over the past decade. While the company's 10-year median is 5.54 vs. the industry median of 5.47, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current OCF Yield % of 8.38 is 53.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current OCF Yield % is 8.38, which is 51% above median its own 10-year median of 5.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,582.89, compared to a current price of Rp900.00 — trading 43.1% below its estimated fair value. The current OCF Yield % is 8.38, which is 51% above median its 10-year median of 5.54 and 53.2% above the Healthcare Providers & Services industry median of 5.47. PT Medikaloka Hermina Tbk's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current OCF Yield % is 8.38 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp900.00 is trading 43.1% below its estimated GF Value™ of Rp1,582.89.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
OCF Yield %: 8.38 (51% above median its 10-year median of 5.54)
GF Value™: Rp1,582.89 vs. price of Rp900.00 (43.1% below fair value)
Industry Position: 53.2% above the Healthcare Providers & Services median (#248 of 683)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
72GF Score
Get the complete analysis for ISX:HEAL
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
